Elixxer Correlations
| ELIXF Stock | USD 0.01 0.02 68.45% |
The current 90-days correlation between Elixxer and BellRock Brands is 0.03 (i.e., Significant diversification). The correlation of Elixxer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Elixxer Correlation With Market
Significant diversification
The correlation between Elixxer and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Elixxer and DJI in the same portfolio, assuming nothing else is changed.
Elixxer |
The ability to find closely correlated positions to Elixxer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elixxer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elixxer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elixxer to buy it.
Moving against Elixxer Pink Sheet
| 0.75 | TEVA | Teva Pharma Industries Aggressive Push | PairCorr |
| 0.73 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.58 | HLN | Haleon plc Aggressive Push | PairCorr |
| 0.57 | HLNCF | Haleon plc | PairCorr |
| 0.41 | MKKGY | Merck KGaA ADR | PairCorr |
| 0.41 | BIMT | Bitmis Corp | PairCorr |
| 0.4 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.35 | MKGAF | MERCK Kommanditgesells | PairCorr |
| 0.34 | FCTI | Fact Inc | PairCorr |
| 0.73 | APGE | Apogee Therapeutics, | PairCorr |
| 0.69 | AKAM | Akamai Technologies | PairCorr |
| 0.68 | HL | Hecla Mining Aggressive Push | PairCorr |
| 0.68 | DDS | Dillards, | PairCorr |
| 0.67 | GM | General Motors | PairCorr |
| 0.67 | IDN | Intellicheck Mobilisa | PairCorr |
| 0.53 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.51 | AVTBF | Avant Brands | PairCorr |
| 0.49 | CHACR | Crane Harbor Acquisition | PairCorr |
| 0.44 | GWW | WW Grainger | PairCorr |
| 0.41 | ALVLF | Big Ridge Gold | PairCorr |
| 0.38 | 68233JBP8 | US68233JBP84 | PairCorr |
| 0.77 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.73 | RLMD | Relmada Therapeutics | PairCorr |
| 0.59 | NOEM | CO2 Energy Transition | PairCorr |
| 0.49 | ULTA | Ulta Beauty | PairCorr |
| 0.47 | ZPTA | Zapata Computing Holdings Buyout Trend | PairCorr |
| 0.41 | EGP | EastGroup Properties | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Elixxer Pink Sheet performing well and Elixxer Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Elixxer's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SNNVF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| DXBRF | 3.12 | (1.63) | 0.00 | (3.87) | 0.00 | 0.00 | 100.00 | |||
| TCNAF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MRMD | 5.75 | (0.16) | 0.00 | 0.58 | 0.00 | 14.29 | 60.95 | |||
| SPBBF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CANSF | 5.87 | (0.20) | 0.00 | (0.34) | 0.00 | 10.00 | 35.38 | |||
| FLOOF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MILFF | 3.73 | (0.33) | 0.00 | 0.99 | 0.00 | 0.00 | 110.00 | |||
| VEXTF | 4.49 | (0.16) | 0.00 | 0.32 | 0.00 | 11.11 | 30.00 | |||
| CXXIF | 7.12 | 0.18 | 0.04 | 0.13 | 7.74 | 12.50 | 81.83 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Elixxer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Elixxer Corporate Management
| CPA CMA | Co CFO | Profile | |
| Jeanne Wyk | VP Communications | Profile | |
| Ferras Zalt | Chairman CEO | Profile | |
| Michael Kozub | Co Sec | Profile | |
| LLB LLB | Legal Council | Profile | |
| Daniel Lubienietzky | VP Devel | Profile | |
| Richard Widmann | EVP Commercial | Profile |